» Articles » PMID: 20014752

Cheminformatics Analysis of Assertions Mined from Literature That Describe Drug-induced Liver Injury in Different Species

Overview
Specialty Toxicology
Date 2009 Dec 18
PMID 20014752
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39-44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds' chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure-activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.

Citing Articles

Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis.

Sharma G, Kumar N, Sharma C, Alqahtani T, Tiruneh Y, Sultana S Sci Rep. 2025; 15(1):2830.

PMID: 39843610 PMC: 11754916. DOI: 10.1038/s41598-025-86016-9.


Improved Detection of Drug-Induced Liver Injury by Integrating Predicted and Data.

Seal S, Williams D, Hosseini-Gerami L, Mahale M, Carpenter A, Spjuth O Chem Res Toxicol. 2024; 37(8):1290-1305.

PMID: 38981058 PMC: 11337212. DOI: 10.1021/acs.chemrestox.4c00015.


Improved Detection of Drug-Induced Liver Injury by Integrating Predicted and Data.

Seal S, Williams D, Hosseini-Gerami L, Mahale M, Carpenter A, Spjuth O bioRxiv. 2024; .

PMID: 38895462 PMC: 11185581. DOI: 10.1101/2024.01.10.575128.


Hybrid non-animal modeling: A mechanistic approach to predict chemical hepatotoxicity.

Chung E, Wen X, Jia X, Ciallella H, Aleksunes L, Zhu H J Hazard Mater. 2024; 471():134297.

PMID: 38677119 PMC: 11519847. DOI: 10.1016/j.jhazmat.2024.134297.


Multifunctional effect of flavonoids from against Alzheimer's disease pathogenesis.

Arsito P, Waiwut P, Yenjai C, Arthan S, Monthakantirat O, Nualkaew N Heliyon. 2023; 9(11):e21894.

PMID: 38106662 PMC: 10722324. DOI: 10.1016/j.heliyon.2023.e21894.


References
1.
Blomme E, Yang Y, Waring J . Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol Lett. 2008; 186(1):22-31. DOI: 10.1016/j.toxlet.2008.09.017. View

2.
Zhu H, Tropsha A, Fourches D, Varnek A, Papa E, Gramatica P . Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis. J Chem Inf Model. 2008; 48(4):766-84. DOI: 10.1021/ci700443v. View

3.
Meier P, Schmid M, Staubli M . [Acute hepatitis following administration of fansidar]. Schweiz Med Wochenschr. 1990; 120(7):221-5. View

4.
Ballet F . Hepatotoxicity in drug development: detection, significance and solutions. J Hepatol. 1997; 26 Suppl 2:26-36. DOI: 10.1016/s0168-8278(97)80494-1. View

5.
Suter W . Predictive value of in vitro safety studies. Curr Opin Chem Biol. 2006; 10(4):362-6. DOI: 10.1016/j.cbpa.2006.06.023. View